About the Company
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $KRYS News
Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results
Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.
Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...
Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript
Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript February 26, 2024 Krystal Biotech, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third ...
What Makes Krystal Biotech, Inc. (KRYS) a New Buy Stock
Krystal Biotech, Inc. (KRYS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Krystal Biotech Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Krystal Biotech, Inc. (KRYS) Tops Q4 Earnings and Revenue Estimates
Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of a loss of $0.52 per share. This compares to loss of $1.25 per share a year ...
Krystal Biotech shares up sharply after it logs revenue from newly approved product
Krystal Biotech Inc.'s stock shot up 30% Monday on the Nasdaq stock exchange after the launch of Krystal Biotech's first FDA-approved product in 2023 brought the first stream of revenue for the ...
Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why
There are several stocks that passed through the screen and Krystal Biotech, Inc. (KRYS) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing.
Krystal Biotech, Inc. (KRYS) Q4 2023 Earnings Call Transcript
Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode. After the ...
Krystal Biotech Inc 4KB
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Q4 2023 Krystal Biotech Inc Earnings Call
Krish Krishnan; Chairman & CEO; Krystal Biotech, Inc. Suma Krishnan; President of Research & Development; Krystal Biotech, Inc. Kate Romano; Executive VP & CAO ...
Loading the latest forecasts...